1. Home
  2. OMH vs AYTU Comparison

OMH vs AYTU Comparison

Compare OMH & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

HOLD

Current Price

$0.80

Market Cap

24.4M

Sector

Finance

ML Signal

HOLD

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

HOLD

Current Price

$2.18

Market Cap

27.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMH
AYTU
Founded
2015
N/A
Country
Singapore
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.4M
27.4M
IPO Year
2022
2015

Fundamental Metrics

Financial Performance
Metric
OMH
AYTU
Price
$0.80
$2.18
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
N/A
$9.33
AVG Volume (30 Days)
17.4K
50.9K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$27,632,080.00
Revenue This Year
$28.40
N/A
Revenue Next Year
$23.07
$43.75
P/E Ratio
N/A
N/A
Revenue Growth
N/A
277.47
52 Week Low
$0.59
$1.46
52 Week High
$3.25
$3.07

Technical Indicators

Market Signals
Indicator
OMH
AYTU
Relative Strength Index (RSI) 32.26 34.14
Support Level $0.75 $2.15
Resistance Level $1.38 $2.30
Average True Range (ATR) 0.05 0.11
MACD -0.00 -0.03
Stochastic Oscillator 11.72 28.91

Price Performance

Historical Comparison
OMH
AYTU

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: